BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 11, 2011
View Archived Issues
TopoTarget patents new NAmPRTase inhibitors
Read More
Cellzome discloses novel tyrosine-protein kinase ZAP-70 inhibitors
Read More
Abraxis claims new proto-oncogene tyrosine-protein kinase Src inhibitors
Read More
New inhibitors claimed of DNA gyrase and/or DNA topoisomerase 4
Read More
Anticocaine vaccine dAd5GNC shows promise in mice
Read More
Methylation of FMR1 promoter may predict response to AF-Q056 in fragile X syndrome
Read More
GSK discloses new lysophospholipid S1P1 receptor agonists
Read More
Merck & Co. patents new Egl nine homolog inhibitors
Read More
Amgen grants MedImmune rights to develop AMG-108 worldwide outside Japan
Read More
Profectus' multiantigen HIV pDNA vaccine enters phase I trial
Read More
ATX-101 enters European phase III trials for reduction of submental fat
Read More
Bristol-Myers Squibb and AstraZeneca launch Kombiglyze in U.S.
Read More
Eusa Pharma obtains FDA priority review status for Erwinaze BLA
Read More
FDA approves Abstral for breakthrough cancer pain
Read More
EMA and FDA grant expedited review for boceprevir
Read More
Rivaroxaban filed for approval in E.U. and U.S. for stroke prevention and other indications
Read More
Enrollment begins in phase III regorafenib trial in gastrointestinal stromal tumors
Read More
New indication for Lucentis in E.U. for vision loss in diabetic macular edema
Read More
EB-1010 improves symptoms of major depressive disorder
Read More
Forest Laboratories launches Teflaro in U.S.
Read More
Inhibitex reports interim safety and antiviral data from phase Ib INX-189 trial
Read More
ELN-457946 reduces restenosis in porcine model combining endothelial denudation and stent placement
Read More
Acceleron receives grant to develop ACE-031 for DMD
Read More
Sandoz initiates phase II trial of its biosimilar rituximab
Read More
Lexicon reports phase II data on LX-4211 in type 2 diabetes
Read More
